Upregulation of autophagy by hypoxia-inducible factor-1α promotes EMT and metastatic ability of CD133+ pancreatic cancer stem-like cells during intermittent hypoxia
- PMID: 24994549
- DOI: 10.3892/or.2014.3298
Upregulation of autophagy by hypoxia-inducible factor-1α promotes EMT and metastatic ability of CD133+ pancreatic cancer stem-like cells during intermittent hypoxia
Abstract
Epithelial-to-mesenchymal transition (EMT) facilitates the escape of pancreatic cancer cells from the primary tumor site, which is a key early event in metastasis. In the present study, we examined if intermittent hypoxia facilitates the invasiveness of human pancreatic cancer cell lines (Panc-1 and BxPC-3) by Transwell assay. We used western blotting and flow cytometry analysis to quantify stem-like cells in the migratory cells during intermittent hypoxia in the human pancreatic cancer cells. Under normoxia or intermittent hypoxia, the expression of autophagy-related proteins (LC3-II and Beclin), hypoxia-inducible factor-1α (HIF-1α) and EMT-related markers (E-cadherin, Vimentin and N-cadherin) was examined by western blotting. siRNA and the autophagic inhibitor were used to access the role of HIF-1α and autophagy in promoting metastasis and EMT. Under intermittent hypoxia, pancreatic cancer cells demonstrated enhanced invasive ability and enriched stem-like cells. The migratory cells displayed stem-like cell characteristics and elevated the expression of LC3-II and Beclin-1, HIF-1α, E-cadherin, Vimentin and N-cadherin under intermittent hypoxia conditions. Moreover, enhanced autophagy was induced by the elevated level of HIF-1α. The metastatic ability and EMT of pancreatic cancer stem cells was associated with HIF-1α and autophagy. This novel finding may indicate the specific role of HIF-1α and autophagy in promoting the metastatic ability of pancreatic cancer stem cells. Additionally, it emphasizes the importance of developing therapeutic strategies targeting cancer stem cells and autophagy to reduce metastasis.
Similar articles
-
Hypoxia induces tumor aggressiveness and the expansion of CD133-positive cells in a hypoxia-inducible factor-1α-dependent manner in pancreatic cancer cells.Pathobiology. 2011;78(4):181-92. doi: 10.1159/000325538. Epub 2011 Jul 19. Pathobiology. 2011. PMID: 21778785
-
CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells.Int J Mol Sci. 2016 Jun 28;17(7):1025. doi: 10.3390/ijms17071025. Int J Mol Sci. 2016. PMID: 27367674 Free PMC article.
-
Effects of the HIF-1α and NF-κB loop on epithelial-mesenchymal transition and chemoresistance induced by hypoxia in pancreatic cancer cells.Oncol Rep. 2014 Apr;31(4):1891-8. doi: 10.3892/or.2014.3022. Epub 2014 Feb 11. Oncol Rep. 2014. PMID: 24535079
-
HIF-1--a big chapter in the cancer tale.Exp Oncol. 2016 Mar;38(1):9-12. Exp Oncol. 2016. PMID: 27031712 Review.
-
Pancreatic cancer stem cells: their role in pancreatic cancer patient outcomes and what is future?JOP. 2013 Jul 10;14(4):401-4. doi: 10.6092/1590-8577/1658. JOP. 2013. PMID: 23846937 Review.
Cited by
-
Galectins and galectin-mediated autophagy regulation: new insights into targeted cancer therapy.Biomark Res. 2023 Feb 22;11(1):22. doi: 10.1186/s40364-023-00466-9. Biomark Res. 2023. PMID: 36814341 Free PMC article. Review.
-
Therapeutic Targeting Hypoxia-Inducible Factor (HIF-1) in Cancer: Cutting Gordian Knot of Cancer Cell Metabolism.Front Genet. 2022 Mar 31;13:849040. doi: 10.3389/fgene.2022.849040. eCollection 2022. Front Genet. 2022. PMID: 35432450 Free PMC article. Review.
-
Hypoxia signaling in human health and diseases: implications and prospects for therapeutics.Signal Transduct Target Ther. 2022 Jul 7;7(1):218. doi: 10.1038/s41392-022-01080-1. Signal Transduct Target Ther. 2022. PMID: 35798726 Free PMC article. Review.
-
Cancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic Cancer.Cancers (Basel). 2022 Dec 22;15(1):61. doi: 10.3390/cancers15010061. Cancers (Basel). 2022. PMID: 36612058 Free PMC article. Review.
-
Chronic intermittent hypoxia enhances disease progression in myeloma-resistant mice.Am J Physiol Regul Integr Comp Physiol. 2019 May 1;316(5):R678-R686. doi: 10.1152/ajpregu.00388.2018. Epub 2019 Mar 20. Am J Physiol Regul Integr Comp Physiol. 2019. PMID: 30892915 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials